Litcius/Paper detail

Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)

Constance Thibault, Aude Fléchon, Laurence Albigès, Charlotte Joly, Philippe Barthélémy, Marine Gross-Goupil, Christine Chevreau, Elodie Coquan, Frédéric Rolland, Brigitte Laguerre, Gwénaëlle Gravis, Nicolas Pécuchet, Réza-Thierry Elaidi, Marc‐Olivier Timsit, Meryem Brihoum, Édouard Auclin, Aurélien de Reyniès, Yves Allory, Stéphane Oudard

2023European Journal of Cancer19 citationsDOI

Topics & Concepts

GemcitabineBevacizumabMedicineOncologyChemotherapyInternal medicineMedullary cavityCabozantinibRenal cell carcinomaRenal cell carcinoma treatmentPancreatic and Hepatic Oncology ResearchBladder and Urothelial Cancer Treatments